Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/24/23 17:37 | 11/21/23 | IOBT | Health | Drug | Pharmaceutical Preparations | Burkavage Brian | G7 | O | Chief Ac | 1 | P.m | 10 | 1.01 | 0 | 10 | 667 | 12 | D | ||||||||||||||
8/11/23 16:31 | 8/9/23 | IOBT | Health | Drug | Pharmaceutical Preparations | Novo Holdings A/s | G7 | T | 1 | P.d | 5,000 | 2.03 | 0 | 2,469 | 76 | 5,707 | D | |||||||||||||||
8/10/23 09:03 | 8/9/23 | IOBT | Health | Drug | Pharmaceutical Preparations | Vivo Capital Ix, LLC | CA | T | 1 | P.d | 6,000 | 1.90 | 0 | 3,158 | 105 | 6,173 | I | |||||||||||||||
3/20/23 17:35 | 3/17/23 | IOBT | Health | Drug | Pharmaceutical Preparations | Sullivan Amy | G7 | O | CFO | 1 | P | 58 | 2.32 | 0 | 25 | 25 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |